2019台灣生技月 Bio Taiwan 生物科技大展

2019 台灣生技月 南港展覽館

SATELLITE EVENTS

Technology Showcase - Exploring Licensing Opportunity from Japan




Technology Showcase-Exploring Licensing Opportunity from Japan          
 
【Date】July 23rd, Tuesday, 2019
【Venue】Rm 503, 5F, Taipei Nangang Exhibition Center, Hall 1
 (No.1, Jingmao 2nd Rd., Nangang District, Taipei)
【Organizer】BioMed Commercialization Center  (www.biip-dcc.org)
【Registration link】https://lihi1.cc/BXBhH

 

        In 2016, Taiwan government proposed a “biomedical industrial innovation promotion program (BIIP)”, to facilitate development of Taiwan’s biomedical industry. BioMed Commercialization Center (BMCC), under BIIP, was established to consolidate resources, incubate startups, and strengthen technical support platforms for industrial and academic research.
        To strengthen international collaboration, BMCC has approached the international society for project sourcing and screening since 2018.  BMCC hopes to introduce potential projects to Taiwan and enrich the pipeline for local biotech industry.
        Together with BioAsia Taiwan 2019, BMCC is inviting Kyoto University, KinoPharma and Hokkaido University, to introduce three novel anti-cancer technologies to Taiwan industry.  The one-on-one partnering meeting is arranged for further business discussion. If you are interested in technology licensing or co-development opportunity with Japan, please join us.
 

Time Topic Speaker
 9:00-9:05   Opening  
9:05-9:30   抗病毒藥 Abacavir在成人T細胞白血病之應用
(臨床2期)
  高折晃史 教授
  京都大學醫學研究所血液腫瘤科主任
  京都大學醫院副院長
    Repurposing anti-HIV drug Abacavir for adult
  T-cell leukemia
 
  Akifumi Takaori-Kondo, MD, PhD, 
  Professor and Chairman
  Department of Hematology and Oncology
  Graduate School of Medicine
  Kyoto University
9:30-9:55   子宮頸上皮內贅瘤之外用藥物開發
(臨床1/2期)
  黒石眞史 社長
  日本KinoPharma株式會社
    Safe topical treatment for Cervical Intraepithelial
  Neoplasia (CIN)
  Masafumi Kuroishi                 
  CEO, KinoPharma, Inc.
 
9:55-10:20   創新抗癌藥物: ARF6訊息傳遞對 PD-L1回收與癌症
  免疫規避之影響(臨床前)
  佐邊壽孝 教授
  北海道大學醫學研究所分子生物系
   
  ARF6-AMAP1 pathway drives PD-L1 recycling
  and cancer immune evasion via promoting 
  eIF4A/4E- dependent mRNA translation and
  the mevalonate pathway
 
  Sabe Hisataka, PhD, Professor
  Department of Molecular Biology
  Graduate School of Medicine
  Hokkaido University
10:20-10:30   Break  
10:30-11:20   綜合座談 
  Panel Discussion
 
  主持人:
  台耀化學 楊志平執行長
  與談人:
  京都大學 高折晃史教授
  KinoPharma 黒石眞史社長
  北海道大學 佐邊壽孝教授
  陳晨 德國默克藥廠 外部創新部
  林國鐘 藥華醫藥 創辦人暨執行長
 
  Moderator:
  Dr. Chih-Ping Yang, CEO, Formosa Lab ,          Taiwan
  Panelists:
  Prof. Akifumi Takaori-Kondo
  Mr. Masafumi Kuroishi
  Prof. Sabe Hisataka
  Dr. Michael Chen, Head of External                    Innovation China, Merck KGaA.
  Dr. KoChung Lin, Founder and CEO,                PharmaEssentia, Taiwan
 
11:25-12:00   一對一媒合會議
  One-on-one meeting
 
 
  • The one-on-one meeting for on-line registrants will be arranged in high priority than on-site registrants
  • Conference will be conducted in English
  • The organizer reserves the right to change the event program and decide upon admitting participants.